# Lotus Pharmaceutical Co., Ltd. – FDA Inspection, Apr 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/99a4af9e-28dc-44c1-a9cb-88210f19ecb4
Source feed: FDA_Inspections

> FDA inspection 1236763 of Lotus Pharmaceutical Co., Ltd., April 12, 2024. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236763
- Company Name: Lotus Pharmaceutical Co., Ltd.
- Inspection Date: 2024-04-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- FDA Inspection 1095930 - 2019-05-31
- [FDA Inspection 1028353 - 2017-09-22](https://www.keypedia.com/records/fda_inspections/lotus-pharmaceutical-co-ltd/c9a55bfd-d912-4152-91fb-6814241d953d)
- FDA Inspection 933276 - 2015-06-04
- FDA Inspection 797095 - 2012-08-16
- FDA Inspection 655757 - 2010-02-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)

Company: https://www.keypedia.com/companies/lotus-pharmaceutical-co-ltd/1043820e-dbbd-403f-b81f-fc75b7ed8ab7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c